EPCORE FL-1: Phase 3 trial of subcutaneous epcoritamab with rituximab and lenalidomide (R (2)) Vs R (2) alone in patients with relapsed or refractory follicular lymphoma Meeting Abstract
| Authors: | Falchi, L.; Morschhauser, F.; Linton, K.; Huang, H.; Galderisi, F.; Quadri, S.; Zeng, L.; Hoehn, D.; Seymour, J. F. |
| Abstract Title: | EPCORE FL-1: Phase 3 trial of subcutaneous epcoritamab with rituximab and lenalidomide (R (2)) Vs R (2) alone in patients with relapsed or refractory follicular lymphoma |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 3053 |
| Language: | English |
| ACCESSION: | WOS:001159740302162 |
| DOI: | 10.1182/blood-2023-180092 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
